Tilray Brands (TLRY) Profit After Tax Growth (1y) (2018 - 2026)
Tilray Brands (TLRY) Profit After Tax Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | -303.53% |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | -5.04% |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | -17.27% |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | 7.59% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -2,482.61% |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | 34.32% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 390.91% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Tilray Brands | 516.11 Mn | 281.48 Mn | 90.52 Mn | 96.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 96.07% |
| Feb 28, 2026 | 96.06% |
| Nov 30, 2025 | 58.57% |
| Aug 31, 2025 | 104.35% |
| May 31, 2025 | -3,878.59% |
| Feb 28, 2025 | -628.42% |
| Nov 30, 2024 | -129.97% |
| Aug 31, 2024 | 42.09% |
| May 31, 2024 | 77.70% |
| Feb 29, 2024 | 90.83% |
| Nov 30, 2023 | 60.55% |
| Aug 31, 2023 | 60.25% |
| May 31, 2023 | 71.52% |
| Feb 28, 2023 | -2,378.71% |
| Nov 30, 2022 | -142.27% |
| Aug 31, 2022 | 2.63% |
| May 31, 2022 | -1,159.05% |
| Feb 28, 2022 | 118.68% |
| Nov 30, 2021 | 52.45% |
| Aug 31, 2021 | -568.13% |